Skip to main content

    Conflict of interest policy

    A site about peptides, regulators, and counterfeit medicine is only useful if its commercial relationships are visible. This is the full disclosure.

    Commercial relationships we do have

    Affiliate link — Peptide Barn (research peptides)

    Peptide Authority earns a commission when readers buy from Peptide Barn via an affiliate link. This relationship is disclosed on pages where the link or supplier CTA appears. We do not rank vendors, run a 'best peptide shop' list, or steer readers toward unregulated sellers.

    Commercial relationships we do not have

    No clinic relationships

    We do not own, run, or have a paid relationship with any peptide clinic, telehealth provider, or prescriber.

    No paid medical reviewers

    Our review roles are described publicly and are not paid endorsements. Until we have named, verifiable reviewers, those slots are explicitly marked 'pending appointment'.

    No sponsored editorial

    We do not accept payment to write peptide profiles, comparisons, claim reviews, or safety pages. We do not sell guest posts.

    No supplier influence over evidence grading

    Our evidence grades (A–E, plus R and S) are set by the editorial team and reviewers, not by the affiliate retailer or any commercial party.

    No pharmaceutical sponsorship

    We have no funding or commercial relationship with manufacturers of GLP-1 medicines, growth hormone secretagogues, or any other compounds we cover.

    Editorial firewall — how we keep affiliate revenue away from editorial decisions

    • The affiliate retailer does not see content before publication.
    • The affiliate retailer cannot request changes to evidence grades, safety warnings, or regulatory framing.
    • Content decisions (what to publish, when to retract, how strongly to warn) sit with the editorial team.
    • We do not insert affiliate links into safety, legal, regulatory, or trust pages — including this page.
    • Pages discussing prescription-only medicines (GLP-1 etc.) point to regulated UK pharmacy access routes, not the affiliate retailer.
    • Where the affiliate CTA appears on a peptide page, it is accompanied by a visible disclosure linking back to this policy.

    Why this matters for reader safety

    The peptide space has well-known incentive problems: clinics that earn from prescriptions, sellers that earn from grey-market supply, and content sites that earn from sending traffic to unregulated vendors. Readers cannot evaluate evidence grading, safety wording, or regulatory framing without knowing where the publisher makes its money.

    If at any point you read content on this site that seems to be steering you toward unregulated purchase, away from prescribed medicines, or away from speaking to a qualified clinician, please flag it via our corrections policy so we can investigate.

    If our relationships change

    If we add another commercial relationship — for example, an ad partner, a sponsor, or a second affiliate — this page will be updated and the last-reviewed date below will reflect the change. Material changes will also be noted in our public corrections log.

    Last reviewed:

    Next review due:

    Spotted an error or something out of date? Send a correction.